{"id":566832,"date":"2021-07-15T13:54:15","date_gmt":"2021-07-15T13:54:15","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/"},"modified":"2021-07-15T13:54:15","modified_gmt":"2021-07-15T13:54:15","slug":"rameda-acquires-new-molecule-dana-gas-isnt-complaining","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","title":{"rendered":"Rameda acquires new molecule, Dana gas isn\u2019t complaining"},"content":{"rendered":"

<\/a> EGX-listed<\/strong><\/sup> Rameda Pharma has acquired an new anticoagulant molecule, <\/strong>the company said in a press release this morning (pdf)<\/a>. The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the acquisition will be its largest to date and will see the company \u201cbenefit from a large and fast-growing therapeutic area that has displayed a 3-year CAGR of c.67% between 2017 and 2020.\u201d<\/p>\n

FACT CHECK- <\/strong>Azimut has not yet committed to starting an FX fund, but is simply <\/strong>mulling the idea, <\/strong>Azimut MD Ahmed Abo El Saad tells us, refuting a story that broke yesterday in the local press<\/a>.<\/p>\n

Dana<\/strong><\/sup> Gas is, for once, happy with our arrears payments<\/strong>, reporting in a release (pdf<\/a>) that 1H2021 collections from Kurdistan and Egypt have increased 106% y-o-y to USD 185 mn \u2014 the highest level in more than five years. Dana, which routinely complains loudly about the pace at which Egypt pays it, was reported in April to be in arbitration with IPR Wastani<\/a> after Dana reneged on an agreement to sell most of its on-shore Egypt assets in a USD 236 mn transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"

EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the acquisition will be its largest […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[10103],"tags":[3305,110,633,449,4202],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-566832","post","type-post","status-publish","format-standard","hentry","category-speed-round-catch-up-quick","tag-azimut-egypt-asset-management","tag-dana-gas","tag-enterprisepm","tag-rameda-pharma","tag-speed-round-catch-up-quick","wpautop","entry"],"acf":{"mongo_id":"f139a979-0e9a-4496-b8d9-3623a86ebe6e","is_powered_by":true,"story_type":"1","photo_url":"","photo_position":"above","related_issue":[566822],"teaser":"","voice_url":""},"yoast_head":"\nRameda acquires new molecule, Dana gas isn\u2019t complaining - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rameda acquires new molecule, Dana gas isn\u2019t complaining\" \/>\n<meta property=\"og:description\" content=\"EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the acquisition will be its largest […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-15T13:54:15+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Rameda acquires new molecule, Dana gas isn\u2019t complaining\",\"datePublished\":\"2021-07-15T13:54:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\"},\"wordCount\":205,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"Azimut Egypt Asset Management\",\"Dana Gas\",\"EnterprisePM\",\"Rameda Pharma\",\"SPEED ROUND: CATCH UP QUICK\"],\"articleSection\":[\"SPEED ROUND: CATCH UP QUICK\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\",\"name\":\"Rameda acquires new molecule, Dana gas isn\u2019t complaining - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2021-07-15T13:54:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rameda acquires new molecule, Dana gas isn\u2019t complaining\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rameda acquires new molecule, Dana gas isn\u2019t complaining - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","og_locale":"en_US","og_type":"article","og_title":"Rameda acquires new molecule, Dana gas isn\u2019t complaining","og_description":"EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the acquisition will be its largest […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2021-07-15T13:54:15+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Rameda acquires new molecule, Dana gas isn\u2019t complaining","datePublished":"2021-07-15T13:54:15+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/"},"wordCount":205,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["Azimut Egypt Asset Management","Dana Gas","EnterprisePM","Rameda Pharma","SPEED ROUND: CATCH UP QUICK"],"articleSection":["SPEED ROUND: CATCH UP QUICK"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","url":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","name":"Rameda acquires new molecule, Dana gas isn\u2019t complaining - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2021-07-15T13:54:15+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Rameda acquires new molecule, Dana gas isn\u2019t complaining"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":570490,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/04\/02\/rameda-acquires-generic-anti-inflammatory-molecule\/","url_meta":{"origin":566832,"position":0},"title":"Rameda acquires generic anti-inflammatory molecule","author":"enterpriseam admin","date":"2 April 2020","format":false,"excerpt":"Rameda Pharma has acquired a generic anti-inflammatory molecule, according to a statement (pdf). The unnamed molecule, which relieves pain associated with rheumatoid arthritis, psoriatic arthritis, osteoarthritis and other chronic ailments, would have been among Rameda\u2019s top-10 selling products had it been in its lineup in 2019. An independent market research\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":547325,"url":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","url_meta":{"origin":566832,"position":1},"title":"Rameda gets its hands on a new molecule","author":"enterpriseam admin","date":"16 June 2022","format":false,"excerpt":"Rameda has acquired a molecule used for treating epilepsy, the pharma company said in a disclosure to the EGX (pdf) yesterday. Known as Lacovimp, the molecule reduces the frequency and severity of partial seizures and was described by the company as \u201cthe fastest-growing product within the local market for its\u2026","rel":"","context":"In "Also on our Radar"","block_context":{"text":"Also on our Radar","link":"https:\/\/enterpriseam.com\/egypt\/category\/also-on-our-radar\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":595863,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/08\/08\/azimut-completes-acquisition-of-rasmala-asset-management-subsidiary\/","url_meta":{"origin":566832,"position":2},"title":"Azimut completes acquisition of Rasmala asset management subsidiary","author":"enterpriseam admin","date":"8 August 2019","format":false,"excerpt":"M&A WATCH- Azimut completes acquisition of Rasmala subsidiary in EGP 211.3 mn transaction: Italy-based asset manager Azimut Group acquired 100% of Rasmala Egypt Asset Management (REAM) from its parent company Rasmala Group, according to the local press. Azimut bought 499k shares for EGP 211.3 mn. Azimut had signed the agreement\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":595623,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/08\/01\/azimut-gets-greenlight-to-acquire-rasmala-subsidiary\/","url_meta":{"origin":566832,"position":3},"title":"Azimut gets greenlight to acquire Rasmala subsidiary","author":"enterpriseam admin","date":"1 August 2019","format":false,"excerpt":"M&A WATCH- Azimut gets green light to acquire Rasmala subsidiary: The Financial Regulatory Authority (FRA) has approved Italy-based asset manager Azimut Group\u2019s acquisition of 100% of Rasmala Egypt Asset Management (REAM) from its parent company Rasmala Group, REAM chairman and MD Ahmed Abou El-Saad told Al Mal. The transaction, the\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":593913,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/14\/azimut-to-set-up-egypt-focused-equity-fund-before-end-of-2019\/","url_meta":{"origin":566832,"position":4},"title":"Azimut to set up Egypt-focused equity fund before end of 2019","author":"enterpriseam admin","date":"14 October 2019","format":false,"excerpt":"Azimut to set up Egypt-focused equity fund: Italy-based asset manager Azimut Group has completed the procedures to establish a fund to invest in publicly-traded Egyptian companies, Managing Director Ahmed Abu Saad told the local press. The fund will be based in Luxembourg, and is expected to launch before the end\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":567055,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/12\/rameda-among-best-placed-to-capitalize-on-egyptian-pharma-sectors-growth-potential\/","url_meta":{"origin":566832,"position":5},"title":"Rameda among \u201cbest-placed\u201d to capitalize on Egyptian pharma sector\u2019s growth potential","author":"enterpriseam admin","date":"12 January 2020","format":false,"excerpt":"Rameda among \u201cbest-placed\u201d to capitalize on Egyptian pharmasector\u2019s growth potential, sees >50% upside to shares: Egypt\u2019s pharmamarket has significant potential for structural growth, which Rameda is among the \u201cbest-placed\u201d to capitalize on thanks to recent facility expansions and new formulas in the pipeline, HSBC said in a research note out\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/568.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/566832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=566832"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/566832\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/afternoon\/566822"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=566832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=566832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=566832"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=566832"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=566832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}